Evidence map›Paper›PMID 36917581›Full record

ArticlePLoS computational biology2023

Inferring feature importance with uncertainties with application to large genotype data.

Pål Vegard Johnsen, Inga Strümke, Mette Langaas, Andrew Thomas DeWan, Signe Riemer-Sørensen

Open access · goldFull text read
In one paragraph

Article in PLoS computational biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Pål Vegard JohnsenSINTEF DIGITAL, Oslo, Norway.ORCID 0000-0002-2599-7914
Inga StrümkeDepartment of Engineering Cybernetics, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0000-0003-1820-6544
Mette LangaasDepartment of Mathematical Sciences, Norwegian University of Science and Technology, Trondheim, Norway.ORCID 0000-0002-5714-0288
Andrew Thomas DeWanDepartment of Chronic Disease Epidemiology and Center for Perinatal, Pediatric and Environmental Epidemiology, Yale School of Public Health, New Haven, Connecticut, United States of America.
Signe Riemer-SørensenSINTEF DIGITAL, Oslo, Norway.ORCID 0000-0002-5308-7651
Norwegian University of Science and Technology · NOSINTEF · NOProvidence Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Estimating feature importance, which is the contribution of a prediction or several predictions due to a feature, is an essential aspect of explaining data-based models. Besides explaining the model itself, an equally relevant question is which features are important in the underlying data generating process. We present a Shapley-value-based framework for inferring the importance of individual features, including uncertainty in the estimator. We build upon the recently published model-agnostic feature importance score of SAGE (Shapley additive global importance) and introduce Sub-SAGE. For tree-based models, it has the advantage that it can be estimated without computationally expensive resampling. We argue that for all model types the uncertainties in our Sub-SAGE estimator can be estimated using bootstrapping and demonstrate the approach for tree ensemble methods. The framework is exemplified on synthetic data as well as large genotype data for predicting feature importance with respect to obesity.

Indexed as

Genotyping TechniquesUncertainty

Identifiers

PMID36917581
PMCPMC10038287
OpenAlexW4324130407

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read13
table measurements read4
identifiers read8
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.